SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.135-0.9%3:58 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Fitzhughlaw who wrote (812)1/13/2025 3:28:50 PM
From: galt3 Recommendations

Recommended By
Huggenberg
rodneyh07
Stanley Lake 92

  Read Replies (2) of 1230
 
It does not impact the investment. I don't make biotech investments based on individuals. That was my point.
I do make other investments based somewhat on individuals. I'm not gonna go down the Musk road or the PSS road other than to say that I do not find PSS , in the podcast that was shared, to be very impressive or do I agree with many of his views, as stated in the podcast. I do agree, as stated, that chemotherapy is antiquated and harmful, for the most part. Maybe you should watch the podcast and form your own opinion, not that it matters to me, just as mine doesnt matter to you when it comes to people and their impact on this investment. As stated, I have a very large position in IBRX, based on the science, not on PSS. Have a good day, counselor. No bait taking from me. I prefer other types of cologne than musk. Best.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News